Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
13:49:27 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.0566 USD | +5.60% |
|
-5.67% | +1.25% |
| Market Cap | 23.79M 20.5M 19.41M 17.59M 33M 2.27B 33.17M 230M 88.63M 1.16B 89.34M 87.38M 3.65B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 26.52M 22.85M 21.63M 19.61M 36.78M 2.53B 36.97M 257M 98.8M 1.29B 99.58M 97.4M 4.07B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Provectus Biopharmaceuticals, Inc.
| 1 day | +5.60% | ||
| 1 week | -5.67% | ||
| Current month | +0.11% | ||
| 1 month | -8.27% | ||
| 3 months | -17.25% | ||
| 6 months | +0.18% | ||
| Current year | +1.25% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.09 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 2024-04-15 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 2012-05-14 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 2019-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2017-04-02 | |
John Lacey
BRD | Director/Board Member | 78 | 2018-04-26 |
Edward Pershing
CHM | Chairman | 73 | 2018-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/4/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% | ||
| 8/26/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% | ||
| 6/30/26 | Free | Director | 48,917 | 0.5182% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.60% | -5.67% | -16.89% | -43.34% | 22.53M | |
| -2.11% | -1.68% | +44.52% | +95.15% | 68.24B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 62.23B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 27.8B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.86B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.22B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.36B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 17.28B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.46B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 14.23B | |
| Average | -0.26% | -3.96% | +30.84% | +147.15% | 27.27B | |
| Weighted average by Cap. | -0.86% | -3.31% | +33.85% | +133.70% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.53 0.5 0.46 0.86 58.96 0.86 5.98 2.3 30 2.32 2.27 94.78 | 0.34 0.29 0.27 0.25 0.47 32.11 0.47 3.26 1.25 16.34 1.26 1.23 51.62 |
| Net income | -4.76M -4.1M -3.89M -3.52M -6.61M -455M -6.64M -46.14M -17.74M -231M -17.88M -17.49M -731M | -5.43M -4.68M -4.43M -4.02M -7.53M -519M -7.57M -52.62M -20.24M -264M -20.4M -19.95M -834M |
| Net Debt | 2.88M 2.48M 2.35M 2.13M 3.99M 275M 4.01M 27.88M 10.72M 140M 10.81M 10.57M 442M | 2.73M 2.35M 2.23M 2.02M 3.78M 261M 3.8M 26.43M 10.16M 133M 10.24M 10.02M 419M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$0.0566 | +5.60% | 41,500 |
| 26-09-10 | US$0.0536 | +1.71% | 177,617 |
| 26-09-09 | US$0.0527 | -0.75% | 52,072 |
| 26-09-08 | US$0.0531 | -11.50% | 207,865 |
| 26-09-04 | US$0.0600 | +3.90% | 70,811 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
